Qlife: Fully secures ongoing rights issue with top guarantee commitments
Qlife fully secures ongoing rights issue with top guarantee commitments. The top guarantee syndicate amounts to approximately SEK 16.6 million, which corresponds to approximately 28.7 percent of the Rights Issue. Consequently, the Rights Issue is secured to 100 percent through the previously announced subscription undertakings and guarantee commitments and the top guarantee syndicate
Further information about who/whom are the top guarantees will be published as soon as the Swedish Financial Supervisory Authority has approved the new prospectus.
Read more: https://qlifeholding.com/en/news/qlife-fully-secures-ongoing-rights-issue-top-guarantee-commitments
Read about the rights issue here: https://qlifeholding.com/en/news/qlife-publishes-prospectus-due-upcoming-rights-issue-units
Disclaimer: HC Andersen Capital receives payment from Qlife for a Digital IR/Corporate Visibility subscription agreement. /Claus Thestrup 5:40 PM 04-17-2023.
Qlife Holding
Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarkers and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information is facilitated, which can contribute to better treatment and potentially prevent diseases. The first capsules in the company's product, Egoo.Health Platform, were CE-marked for professional use in early 2020. The company has patent protection for key parts of its technology. The Danish-based company is listed on Nasdaq First North Stockholm.
Read more on company page